Mao Shu-Yu, Zhao Chang-Rui, Liu Chang
1. School of Life Science and Technology, China Pharmaceutical University, Nanjing 211198, China.
2. Chongqing Innovation Institute of China Pharmaceutical University, Chongqing 401135, China.
Yi Chuan. 2023 Feb 20;45(2):99-114. doi: 10.16288/j.yczz.22-310.
The physiological processes of mammals show rhythmic changes in a 24-h cycle. Circadian rhythms are under the subtle control of the autonomous circadian clock, and dysregulation of the circadian system can lead to health problems such as metabolic disorders. REV-ERBα, a member of the nuclear receptor superfamily, is an important component of the mammalian circadian clock. REV-ERBα regulates various physiological processes, including the regulation of metabolism, inflammation and immunity as well as the circadian rhythm, making it a potential therapeutic target for metabolic syndrome, inflammatory diseases and cancers. In recent years, an array of new REV-ERBα ligands have been discovered, most of which have potential applications in the treatment of diseases. In this review, we focus on the regulatory role of nuclear receptor REV-ERBα in energy metabolism and inflammation, in order to provide new strategies for the therapy of metabolic syndrome and its related diseases.
哺乳动物的生理过程呈现出24小时周期的节律性变化。昼夜节律受自主生物钟的精细调控,昼夜节律系统失调会导致诸如代谢紊乱等健康问题。核受体超家族成员REV-ERBα是哺乳动物生物钟的重要组成部分。REV-ERBα调节各种生理过程,包括代谢、炎症和免疫调节以及昼夜节律,使其成为代谢综合征、炎症性疾病和癌症的潜在治疗靶点。近年来,一系列新的REV-ERBα配体被发现,其中大多数在疾病治疗中具有潜在应用价值。在本综述中,我们聚焦于核受体REV-ERBα在能量代谢和炎症中的调节作用,以便为代谢综合征及其相关疾病的治疗提供新策略。